Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole MR Timing in Nonerosive Reflux Disease
NCT02490449Unknown
- Sponsor
- Soonchunhyang University Hospital
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexlansoprazole in non-erosive reflux disease (NERD), sponsored by Soonchunhyang University Hospital. Primary endpoint: Percentage of patients free of reflux symptoms at 4 weeks. Status: unknown.
02
Drugs
dexlansoprazole
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT02490449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490449.